Table 2.

Example cardiovascular PGx phenotypes

Cardiovascular PGx Phenotype	Trait or Disease State	Cardiovascular Drug	Drug Response
Blood Pressure Response to Thiazide Diuretics	Change in Blood Pressure in Hypertension patients	Thiazide Diuretic	Post-treatment Blood Pressure - Pre-Treatment Blood Pressure
Bleeding Outcomes after treatment with Warfarin	Atrial Fibrillation	Warfarin	Bleeding events after treatment with Warfarin
Myopathy after treatment with Simvastatin	Hypercholesterolemia	Simvastatin	Myopathy after treatment with Simvastatin
Cardiovascular Outcomes after treatment with Clopidogrel	Percutaneous Coronary Intervention	Clopidogrel	Cardiovascular Outcomes after treatment with Clopidogrel
Elevated Fasting Glucose after treatment with Thiazide Diuretics	Hypertension	Thiazide Diuretic	Post-treatment Fasting Glucose - Pre-treatment Fasting Glucose
Cardiovascular Outcomes after treatment with Calcium Channel Blockers	Hypertension	Calcium Channel Blocker	Difference in Cardiovascular Outcomes in patients treated with Calcium Channel Blockers compared to those not treated with Calcium Channel Blockers

PGx: Pharmacogenomics